Perelman School of Medicine

Penn Research Reveals Where Expectant Parents Turn When Doctors Lack Answers on Prenatal Genetic Health

Humans dislike uncertainty. So what happens when that ambiguity comes from designated “experts” and relates to the genetic health of an unborn child?

Risa Lavizzo-Mourey Appointed Penn Integrates Knowledge Professor

Risa Lavizzo-Mourey has been named the University of Pennsylvania’s 19th Penn Integrates Knowledge University Professor, effective Jan. 1, 2018.

Tired Teens More Likely to Commit Crimes as Adults

Teenagers who self-report feeling drowsy mid-afternoon also tend to exhibit more anti-social behavior such as lying, cheating, stealing and fighting.

Harnessing powerful technology to improve patient care

T Cells Support Long-lived Antibody-producing Cells, Penn-led Team Finds

If you’ve ever wondered how a vaccine given decades ago can still protect against infection, you have your plasma cells to thank. Plasma cells are long-lived B cells that reside in the bone marrow and churn out antibodies against previously encountered vaccines or pathogens.

Penn Medicine: Gene Search Reveals New Mutations, Drug Targets in Rare Adrenal Tumors

Casting one of the largest genomic nets to date for the rare tumors of the autonomic nervous system known as pheochromocytoma and paraganglioma (PCC/PGL) captured several new mutations driving the disease that could serve as potential drug targets, researchers from Penn Medicine and other institutions reported in

Penn Medicine: Orphan Disease Center Partners with Foundation to Study Gene Therapy Approaches to Treat Angelman Syndrome

Penn Medicine’s Orphan Disease Center (ODC) announces a new partnership with the Foundation for Angelman Syndrome Therapeutics or FAST to study gene therapy approaches to treat Angelman syndrome (AS).

CHOP/Penn/Boston Children’s Study: Low Blood Sugar No Benefit to Critically Ill Children

Critically ill infants and children do not gain extra benefit from lower blood-sugar levels, compared to higher levels within the usual care range, according to research from the Children’s Hospital of Philadelphia, the University of Pennsylvania

Anti-Inflammatory, Anti-Cell Death Agent a Potential Treatment for Vision Loss Associated with Multiple Sclerosis

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers in the Perelman School of Medicine at the University of Pennsylvania, with Pittsburgh-based Noveome Biotherapeutics.

Penn Genetics Researcher Receives Grant from Pharmaceutical Consortium to Study Diabetic Kidney Disease

Katalin Susztak, MD, PhD, an associate professor of Medicine and Genetics in the Perelman School of Medicine at the University of Pennsylvania, has received a $3 million grant from a consortium of pharmaceutical companies to identify genes and other characteristics that are signs of rapid decline in kidney function in patients with diabetic kidney disease.

Filters